BIT:1BAX - Euronext Milan - US0718131099 - Common Stock - Currency: EUR
BIT:1BAX (3/7/2025, 7:00:00 PM)
32.895
+0.85 (+2.64%)
The current stock price of 1BAX.MI is 32.895 EUR.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 28.81 | 214.85B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.5 | 28.81B |
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 60,000 full-time employees. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
BAXTER INTERNATIONAL INC
1 Baxter Parkway,
Deerfield ILLINOIS US
Employees: 60000
Company Website: https://www.baxter.com/
Phone: 18442945418
The current stock price of 1BAX.MI is 32.895 EUR. The price increased by 2.64% in the last trading session.
The exchange symbol of BAXTER INTERNATIONAL INC is 1BAX and it is listed on the Euronext Milan exchange.
1BAX.MI stock is listed on the Euronext Milan exchange.
19 analysts have analysed 1BAX.MI and the average price target is 36.84 EUR. This implies a price increase of 11.99% is expected in the next year compared to the current price of 32.895. Check the BAXTER INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BAXTER INTERNATIONAL INC (1BAX.MI) has a market capitalization of 16.78B EUR. This makes 1BAX.MI a Large Cap stock.
BAXTER INTERNATIONAL INC (1BAX.MI) currently has 60000 employees.
The Revenue of BAXTER INTERNATIONAL INC (1BAX.MI) is expected to grow by 3.29% in the next year. Check the estimates tab for more information on the 1BAX.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BAXTER INTERNATIONAL INC (1BAX.MI) has a dividend yield of 3%. The yearly dividend amount is currently 1.16. Check the full fundamental report for a detailed analysis of 1BAX.MI dividend history, reliability and sustainability.
BAXTER INTERNATIONAL INC (1BAX.MI) will report earnings on 2024-10-24, after the market close.
The PE ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 12.7. This is based on the reported non-GAAP earnings per share of 2.59 and the current share price of 32.895 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1BAX.MI.
ChartMill assigns a technical rating of 1 / 10 to 1BAX.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1BAX.MI. 1BAX.MI has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months 1BAX.MI reported a non-GAAP Earnings per Share(EPS) of 2.59. The EPS increased by 1.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 16.51% | ||
ROA | 9.41% | ||
ROE | 32.4% | ||
Debt/Equity | 1.37 |
ChartMill assigns a Buy % Consensus number of 66% to 1BAX.MI. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 10.99% and a revenue growth 3.29% for 1BAX.MI